Cancer immunotherapy candidate provokes powerful dual response in cancer and immune cells
Cancer immunotherapy drugs called PD-1 inhibitors are widely used to stimulate the immune system to fight cancer, but many patients either don't respond or develop resistance to them. A new small-molecule drug candidate being ...
5 hours ago
0
16